23
Participants
Start Date
March 9, 2017
Primary Completion Date
September 12, 2018
Study Completion Date
December 31, 2019
M-Trap
Device(s) will be surgically implanted in the peritoneal cavity. Up to three (3) M-Trap devices will be surgically implanted via laparotomy in the right and left paracolic (pelvic) gutters and behind segment 6 of the liver within the peritoneal cavity of the patient at the time of surgical resection. Patients will receive standard platinum-based chemotherapy. If the cancer is diagnosed to have recurred, M-Trap devices with captured tumor cells will be removed via minimally invasive surgery (laparoscopy).
Castellon University General Hospital, Castelló
Complexo Hospitalario Universitario de Santiago, Santiago de Compostela
MD Anderson Cancer Center, Madrid
Hospital La Paz Madrid, Madrid
Valencia-Hospital General, Valencia
Hospital Universitrio y Politècnico La Fe, Valencia
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Collaborators (1)
MedPass International
INDUSTRY
MTrap, Inc.
INDUSTRY